title: [Comparison of the effectiveness of electrovaporisation, vaporesection and electroresection in the treatment of obstructive symptoms in patients with benign prostate hyperplasia].
abstract: OBJECTIVE
  The aim of this study is the comparison of the efficacy of classical electroresection of the prostate (TURP) and its modern modifications--electrovaporisation (EVAP) and vaporesection (TUVRP) in the treatment of patients with benign prostate hyperplasia (BPH).
  
  
  METHODS
  96 patients were operated on because of BPH. In 31 patients we performed TURP (group I), in 34--EVAP (group II) and in 31--TUVRP (group III). On follow up 1, 3, 6 months post operation we evaluated maximal urine flow (Qmax) and postvoid residual urine (PVR) and compared them to preoperation values.
  
  
  RESULTS
  Mean preoperative values were: 8.98 ml/s and 116.76 ml (group I); 8.64 ml/s and 121.36 ml (group II) and 8.69 ml/s and 112.50 ml (group III). In all patients after 1 month follow up Qmax raised almost twice and after 6 months mean values were respectively in groups I, II, III: 21.62 ml/s; 20.79 ml/s; 22.56 ml/s. PVR diminished in 6 months follow up and mean values were respectively 14.61 ml; 15 ml; 11.25 ml. Differences in these results were of no statistical value.
  
  
  CONCLUSIONS
  The efficacy of TURP, EVAP and TUVRP in the treatment of BPH is comparable. EVAP and TUVRP also diminished risk of intraoperative bleeding.
authors.affiliation: Katedra i Klinika Urologii AM im. L. Rydygiera w Bydgoszczy. klurol@aci.amb.bydgoszcz.pl
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Wolski
authors.forename: Aleksander
authors.initials: A
authors.lastname: Lapuć
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D016063:Blood Loss, Surgical; D004598:Electrosurgery / Q000009:adverse effects / Q000379:methods*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011470:Prostatic Hyperplasia / Q000601:surgery*; D013997:Time Factors; D020728:Transurethral Resection of Prostate / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome